a year ago
LBPH
AnalystsPatrick TrucchioPatrick Trucchio's Stock Forecasts
AnalystsPatrick Trucchio
Analyst Ranking
Bottom 2%
#4788 out of 4868 analysts
Average Return
-4.5%
Win Rate
30%117 out of 392
Risk vs Reward
Poor
Good
Patrick Trucchio's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +410.35% | $6.86 | $35.01 | 2023-08-06 - 2024-08-06 | Buy |
Longboard Pharmaceuticals IncLBPH | +404.91% | $7.33 | $37.01 | 2023-07-10 - 2024-07-10 | Buy |
Sangamo Therapeutics IncSGMO | +388.69% | $0.44 | $2.16 | 2023-11-05 - 2024-11-05 | Buy |
Longboard Pharmaceuticals IncLBPH | +294.36% | $4.79 | $18.89 | 2023-03-14 - 2024-03-14 | Buy |
Silence Therapeutics PLCSLN | +281.43% | $6.03 | $23.00 | 2023-05-17 - 2024-05-17 | Buy |
Patrick Trucchio Analyst Color
Get additional color on Patrick Trucchio's coverage of popular stocks
a year ago
ALT
a year ago
CYBN
3 years ago
VIR
Patrick Trucchio's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Uniqure NvQURE | 14 | Buy | $70.00 | +374.25% | Reiterates | 10 days ago |
Voyager Therapeutics IncVYGR | 10 | Buy | $30.00 | +742.70% | Reiterates | 23 days ago |
Harmony Biosciences Holdings IncHRMY | 6 | Buy | $70.00 | +137.53% | Reiterates | 23 days ago |
Alto Neuroscience IncANRO | 1 | Buy | $10.00 | +301.61% | Initiates Coverage On | 24 days ago |
Sangamo Therapeutics IncSGMO | 24 | Buy | $10.00 | +1,195.34% | Reiterates | 24 days ago |
Beam Therapeutics IncBEAM | 8 | Buy | $80.00 | +301.40% | Reiterates | 24 days ago |
Altimmune IncALT | 17 | Buy | $12.00 | +128.57% | Reiterates | a month ago |
Alnylam Pharmaceuticals IncALNY | 26 | Buy | $500.00 | +89.94% | Reiterates | a month ago |
Milestone Pharmaceuticals IncMIST | 19 | Buy | $10.00 | +657.58% | Maintains | a month ago |
Precision Biosciences IncDTIL | 15 | Buy | $60.00 | +963.83% | Reiterates | a month ago |
Invivyd IncIVVD | 17 | Buy | $10.00 | +1,487.30% | Reiterates | a month ago |
Atai Life Sciences NvATAI | 18 | Buy | $10.00 | +566.67% | Reiterates | a month ago |
Gossamer Bio IncGOSS | 16 | Buy | $10.00 | +880.39% | Reiterates | a month ago |
Immunocore Holdings PLCIMCR | 20 | Buy | $100.00 | +232.23% | Reiterates | 2 months ago |
Oncolytics Biotech IncONCY | 17 | Buy | $5.00 | +775.66% | Reiterates | 2 months ago |
Mind Medicine IncMNMD | 17 | Buy | $55.00 | +760.72% | Reiterates | 2 months ago |
Silence Therapeutics PLCSLN | 23 | Buy | $75.00 | +1,927.03% | Reiterates | 2 months ago |
Compass Pathways PLCCMPS | 12 | Buy | $45.00 | +1,030.65% | Reiterates | 2 months ago |
Vir Biotechnology IncVIR | 22 | Buy | $110.00 | +1,697.39% | Reiterates | 2 months ago |
Bright Minds Biosciences IncDRUG | 2 | Buy | $85.00 | N/A | Reiterates | 2 months ago |
Cybin IncCYBN | 16 | Buy | $150.00 | +2,132.14% | Maintains | 3 months ago |
Arrowhead Pharmaceuticals IncARWR | 22 | Buy | $80.00 | +475.95% | Reiterates | 3 months ago |
Gh Research PLCGHRS | 14 | Buy | $40.00 | +319.29% | Reiterates | 3 months ago |
Longboard Pharmaceuticals IncLBPH | 14 | Hold | $60.00 | +0.03% | Downgrades | 7 months ago |
Freeline Therapeutics Holdings PLCFRLN | 8 | Hold | $6.50 | N/A | Downgrades | a year ago |
Q32 Bio IncQTTB | 5 | Buy | $360.00 | N/A | Reiterates | 2 years ago |
Reunion Neuroscience IncREUN | 3 | Buy | $20.00 | N/A | Reiterates | 2 years ago |
Benitec Biopharma IncBNTC | 2 | Buy | $68.00 | N/A | Maintains | 3 years ago |
F Star Therapeutics IncFSTX | 4 | Hold | $7.00 | N/A | Downgrades | 3 years ago |
Arena Pharmaceuticals IncARNA | 2 | Hold | $100.00 | N/A | Downgrades | 3 years ago |
Allakos IncALLK | 2 | Buy | $20.00 | N/A | Maintains | 3 years ago |
Flexion Therapeutics IncFLXN | 2 | Hold | $10.00 | N/A | Downgrades | 4 years ago |
Mondaycom LtdMNDY | 1 | Buy | $340.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.